Daily Stock Analysis, HSKA, Heska Corp, priceseries

Heska Corp. Daily Stock Analysis
Stock Information
Open
91.73
Close
91.63
High
92.70
Low
91.39
Previous Close
92.21
Daily Price Gain
-0.58
YTD High
102.09
YTD High Date
Feb 4, 2019
YTD Low
62.47
YTD Low Date
Sep 13, 2019
YTD Price Change
1.07
YTD Gain
1.18%
52 Week High
105.00
52 Week High Date
Nov 30, 2018
52 Week Low
62.47
52 Week Low Date
Sep 13, 2019
52 Week Price Change
-6.73
52 Week Gain
-6.84%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Oct 4. 2017
91.38
Oct 19. 2017
96.06
11 Trading Days
5.12%
Link
LONG
Mar 6. 2018
69.01
Mar 28. 2018
77.94
16 Trading Days
12.94%
Link
LONG
May 11. 2018
92.89
Jun 7. 2018
103.04
18 Trading Days
10.93%
Link
Company Information
Stock Symbol
HSKA
Exchange
NasdaqCM
Company URL
http://www.heska.com
Company Phone
9704937272
CEO
Kevin S. Wilson
Headquarters
Colorado
Business Address
3760 ROCKY MOUNTAIN AVENUE, LOVELAND, CO 80538
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001038133
About

Heska Corp. engages in the research, development and manufacture of veterinary products. The company operates through two segments: Core Companion Animal Health and Other Vaccines, Pharmaceuticals & Products. The Core Companion Animal Health segment supplies blood testing instruments, digital imaging software, heartworm diagnostic tests and preventive products, allergy immunotherapy products, and allergy testing. The Other Vaccines, Pharmaceuticals and Products segment develops and distributes vaccines and pharmaceutical products. Its solutions include, dri-chem 4000, 7000, hematrue, element ht5, element i and solo step heartworm. Heska was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.

Description

Heska Corporation develops, manufactures, and markets advanced veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. It operates through two segments, Core Companion Animal Health; and Other Vaccines, Pharmaceuticals and Products. The Core Companion Animal Health segment offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HT5 and HEMATRUE veterinary hematology analyzers to measure white and red blood cell count, platelet count, and hemoglobin levels in animals; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and IV pumps. This segment also provides veterinary imaging instruments and services, such as digital radiography solutions and ultrasound systems, as well as sells mobile digital radiography products; point-of-care heartworm diagnostic test products for dogs and cats; TRI-HEART Plus Chewable Tablets for the preventive treatment of canine heartworm infection, and treatment and control of ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels. The Other Vaccines, Pharmaceuticals and Products segment offers bovine vaccines; biological and pharmaceutical products for other animal health companies; and various turnkey services comprising research, licensing, production, labeling, and packaging, as well as provides validation support and distribution services. The company sells its products to veterinarians through a field organization, a telephone sales force, and independent third-party distributors, as well as trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. Heska Corporation was founded in 1988 and is headquartered in Loveland, Colorado.